Abstract:Monoterpene indole alkaloids (MIAs) are a class of natural products comprised of thousands of structurally unique bioactive compounds with significant therapeutic values. Due to difficulties associated with isolation from native plant species and organic synthesis of these structurally complex molecules, microbial production of MIAs using engineered hosts are highly desired. In this work, we report the engineering of fully integrated Saccharomyces cerevisiae strains that allow de novo access to strictosidine, the universal precursor to thousands of MIAs at 30-40 mg/L. The optimization efforts were based on a previously reported yeast strain that is engineered to produce high titers of the monoterpene precursor geraniol through compartmentalization of mevalonate pathway in the mitochondria. Our approaches here included the use of CRISPR-dCas9 interference to identify mitochondria diphosphate transporters that negatively impact the titer of the monoterpene, followed by genetic inactivation; the overexpression of transcriptional regulators that increase cellular respiration and mitochondria biogenesis. Strain construction included the strategic integration of genes encoding both MIA biosynthetic and accessory enzymes into the genome under a variety of constitutive and inducible promoters. Following successful de novo production of strictosidine, complex alkaloids belonging to heteroyohimbine and corynantheine families were reconstituted in the host with introduction of additional downstream enzymes. We demonstrate that the serpentine/alstonine pair can be produced at ∼5 mg/L titer, while corynantheidine, the precursor to mitragynine can be produced at ∼1 mg/L titer. Feeding of halogenated tryptamine led to the biosynthesis of analogs of alkaloids in both families. Collectively, our yeast strain represents an excellent starting point to further engineer biosynthetic bottlenecks in this pathway and to access additional MIAs and analogs through microbial fermentation. One sentence summary: An Saccharomyces cerevisiae-based microbial platform was developed for the biosynthesis of monoterpene indole alkaloids, including the universal precursor strictosidine and further modified heteroyohimbine and corynantheidine alkaloids.

Metabolic Engineering of Pichia pastoris for Overproduction of Cis-trans nepetalactol

High-level Production of Linalool by Engineered Saccharomyces Cerevisiae Harboring Dual Mevalonate Pathways in Mitochondria and Cytoplasm.

Metabolic engineering of Escherichia coli for N-methylserotonin biosynthesis

Engineered biosynthesis of plant heteroyohimbine and corynantheine alkaloids in Saccharomyces cerevisiae

Biosynthesis of catharanthine in engineered Pichia pastoris

Engineering Microbes for Isoprene Production

Metabolic Engineering of Candida tropicalis for the De Novo Synthesis of β-Ionone

Combinatorial Optimization of MEP Pathway to Improve β-Carotene Yield

Engineering Catharanthus roseus monoterpenoid indole alkaloid pathway in yeast

Yeast Platforms for Production and Screening of Bioactive Derivatives of Rauwolscine

Improved protein glycosylation enabled heterologous biosynthesis of monoterpenoid indole alkaloids and their unnatural derivatives in yeast

Metabolic engineering of microbes for monoterpenoid production

Combinatorial engineering of hybrid mevalonate pathways in Escherichia coli for protoilludene production

Metabolic engineering of Pichia pastoris for myo-inositol production by dynamic regulation of central metabolism

Metabolic engineering of Escherichia coli for the biosynthesis of α-copaene from glucose

Development and optimization of a microbial co-culture system for heterologous indigo biosynthesis

Back to the plant: overcoming roadblocks to the microbial production of pharmaceutically important plant natural products

Engineering a versatile yeast platform for sesquiterpene production from glucose or methanol

Metabolic engineering of Synechocystis sp. PCC 6803 for the improved production of phenylpropanoids

In vitro reconstitution of mevalonate pathway and targeted engineering of farnesene overproduction in Escherichia coli

Engineering Escherichia coli via introduction of the isopentenol utilization pathway to effectively produce geranyllinalool